ALL241220C140000
- 68.80
- 0.000.00%
Allstate Newsroom
Allstate Is Maintained at Overweight by Piper Sandler
Allstate Analyst Ratings
Piper Sandler Maintains Allstate(ALL.US) With Buy Rating, Raises Target Price to $244
Analysts Conflicted on These Financial Names: Allstate (ALL) and Stifel Financial (SF)
KBW Maintains Allstate(ALL.US) With Buy Rating, Maintains Target Price $225
Barclays Maintains Allstate(ALL.US) With Sell Rating, Maintains Target Price $187
Allstate (ALL) Receives a Rating Update From a Top Analyst
Morgan Stanley Maintains Allstate(ALL.US) With Buy Rating, Maintains Target Price $228
BofA Securities Maintains Allstate(ALL.US) With Buy Rating, Raises Target Price to $285
Allstate's Growth and Profitability Potential: Buy Rating Supported by Expanding Underwriting Margins and Strategic Initiatives
Allstate Analyst Ratings
Goldman Sachs Maintains Buy on Allstate, Raises Price Target to $230
Goldman Sachs Adjusts Price Target on Allstate to $230 From $209, Keeps Buy Rating
TD Cowen Maintains Allstate(ALL.US) With Buy Rating, Maintains Target Price $224
TD Cowen Sticks to Its Buy Rating for Allstate (ALL)
Jefferies Maintains Allstate(ALL.US) With Buy Rating, Maintains Target Price $267
Jefferies Maintains Allstate(ALL.US) With Buy Rating, Raises Target Price to $267
Morgan Stanley Maintains Allstate(ALL.US) With Buy Rating, Raises Target Price to $228
Analysts Conflicted on These Financial Names: Swiss Re AG (OtherSSREF) and Allstate (ALL)
Allstate Is Maintained at Outperform by Keefe, Bruyette & Woods